T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy
Ryan Storgard, Kai Rejeski, Miguel‐Angel Perales, Adam Goldman, Roni Shouval
Abstract
This cohort study assesses the increase in second primary malignant neoplasms and T-cell malignant neoplasm cases associated with chimeric antigen receptor–T cells.
Topics & Concepts
MedicineChimeric antigen receptorAntigenNeoplasmCellImmunotherapyCancer researchImmunologyOncologyPathologyInternal medicineCancerBiologyGeneticsCAR-T cell therapy research